[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Medibio Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medibio Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BIOQUAL, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BIOQUAL, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BioQuanta S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioQuanta S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BioSante Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioSante Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BioScience Brands Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioScience Brands Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biosearch SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biosearch SA Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biosensor Applications Sweden AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biosensor Applications Sweden AB Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biosino Bio-Technology and Science Incorporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biosino Bio-Technology and Science Incorporation Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BioSpecifics Technologies Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioSpecifics Technologies Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biostar Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biostar Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biostem US Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biostem US Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biota Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biota Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biotage AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotage AB Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biotec Pharmacon ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotec Pharmacon ASA Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biotech Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotech Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biotest AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotest AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biotie Therapies Oyj Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotie Therapies Oyj Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BioTime, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioTime, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BIOTON S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BIOTON S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biotoxtech Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotoxtech Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biotron Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biotron Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biovest International Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biovest International Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Biovet JSC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Biovet JSC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BioWest Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BioWest Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bioxel Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioxel Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bliss Gvs Pharma Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bliss Gvs Pharma Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BMP Sunstone Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BMP Sunstone Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bohai Pharmaceuticals Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bohai Pharmaceuticals Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Boiron SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Boiron SA Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Botanix Pharmaceuticals Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Botanix Pharmaceuticals Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Boryung Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Boryung Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BPH Corporate Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BPH Corporate Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bradmer Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bradmer Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Brainstorm Cell Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Brainstorm Cell Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Brawn Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Brawn Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bristol-Myers Squibb Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bristol-Myers Squibb Company Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bruker Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bruker Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BTG plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BTG plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bukwang pharm. co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bukwang pharm. co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Burcon Nutrascience Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Burcon Nutrascience Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

C & O Pharmaceutical Technology Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

C & O Pharmaceutical Technology Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Cadence Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cadence Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Cadila Healthcare Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cadila Healthcare Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Cadus Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cadus Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Cairo Pharmaceuticals & Chemical Industries Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cairo Pharmaceuticals & Chemical Industries Co. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Caleco Pharma Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caleco Pharma Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Caliper Life Sciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caliper Life Sciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Callisto Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Callisto Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Calypte Biomedical Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Calypte Biomedical Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Calyx Bio-Ventures Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Calyx Bio-Ventures Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers